Cargando…

Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique

INTRODUCTION: During the COVID-19 pandemic, the containment measures and the recommendations of several societies in oncology may have impacted the request for initial care for cancers. METHODS: In this monocentric retrospective study, the number and the characteristics of patients received for a fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gosset, Marie, Gal, Jocelyn, Schiappa, Renaud, Dejode, Magali, Fouché, Yves, Alazet, Fanny, Roux, Emilie, Delpech, Yann, Barranger, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société Française du Cancer. Published by Elsevier Masson SAS. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690308/
https://www.ncbi.nlm.nih.gov/pubmed/33358012
http://dx.doi.org/10.1016/j.bulcan.2020.10.013
Descripción
Sumario:INTRODUCTION: During the COVID-19 pandemic, the containment measures and the recommendations of several societies in oncology may have impacted the request for initial care for cancers. METHODS: In this monocentric retrospective study, the number and the characteristics of patients received for a first consultation for a breast or gynecologic tumor were compared between the containment period and a control period. The times from diagnosis to treatment and the type of initial care were compared too. RESULTS: During the outbreak, 91 patients were seen for a new request, versus 159 during the control period, a decrease of 43.5 %. Patients were older (62.9 versus 60.9 years old) but this difference was not significant. Tumor stage was not modified. Concerning senology, the time from the biopsy to the first consultation was 5.5 days longer during the outbreak (difference statistically insignificant). Among the 51 patients requiring a surgical treatment during the outbreak, 16 (31.48 %) were postponed after the end of the containment measures. After all, the average time from the consultation to the treatment was not modified. No modification of type of treatment was observed. DISCUSSION: At the height of the pandemic, benefits and risks of the cancer treatment had to be daily balanced against the risk of exposition to the COVID-19. The evaluation of practices for cancer care is essential to understand the real impact of COVID-19 outbreak on global cancer management, so as to get prepared to further crises.